Hypoglycemia After Initiation of Basal Insulin in Patients with Type 2 Diabetes in the United States: Implications for Treatment Discontinuation and Healthcare Costs and Utilization

ConclusionsUS patients with T2D who experienced hypoglycemia within 6  months of basal insulin initiation were more likely to discontinue treatment, accompanied by a greater healthcare burden.FundingSanofi US, Inc.
Source: Advances in Therapy - Category: Drugs & Pharmacology Source Type: research